In comparison to neuroradiology assessment of brain magnetic resonance imaging (MRI) scans for tumor diagnosis, researchers found that adjunctive use of a deep learning system improved diagnostic accuracy by 12.4 percent and sensitivity by 33.5 percent in one test set of 300 patients.
The use of an adjunctive deep learning system, trained with brain magnetic resonance imaging (MRI) scans from over 11,700 patients, provides significantly improved diagnostic accuracy and sensitivity rates for intracranial tumors in comparison to neuroradiologist assessment, according to a new study published in JAMA Network Open.
Utilizing four independent test sets, researchers assessed use of the deep learning system to diagnose intracranial tumors on brain MRI scans from 1,339 patients. In comparison to assessment by neuroradiologists, ranging between 9 to 30 years of experience, adjunctive use of the deep learning system resulted in a 12 percent increase in mean accuracy (75.5 percent vs. 63.5 percent) and a 17.6 percent increase in mean sensitivity (81.4 percent vs. 63.8 percent), according to the study.
Researchers also noted that the deep learning system, which can reportedly provide automated segmentation and classification of up to 18 types of intracranial tumors, improved classification accuracy to 73.3 percent in contrast to a 60.9 accuracy rate for neuroradiologists without the assistance of the deep learning system.
“The results suggest that the (deep learning system) may be able to achieve accuracies comparable with or even higher than those of experienced neuroradiologists in the diagnosis of brain tumors. Furthermore, the (deep learning system) may also be able to perform diagnoses more quickly than evaluators,” wrote Zhenzhou Wu, MSc, who is affiliated with the National Center for Clinical Medicine of Neurological Diseases and the China National Clinical Research Center for Neurological Diseases in Beijing, the People’s Republic of China, and colleagues.
The study authors also reviewed conflict and agreement subsets in their analysis. In the conflict subset of 332 diagnoses, the researchers found that the deep learning system was correct in 219 cases (66 percent) in comparison to 113 correct diagnoses (34 percent) by neuroradiologists without the assistance of the deep learning system.
In regard to study limitations, the authors acknowledged that the training data for the deep learning system were obtained from one institution. They also noted the potential for statistical bias due to a lower number of rare tumors within the training data. Wu and colleagues pointed out that only axial MRI slices were used for the training of the deep learning system and suggested the addition of other MRI views and clinical information could further enhance the performance of the deep learning system.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
Could Ultrafast MRI Enhance Detection of Malignant Foci for Breast Cancer?
April 10th 2025In a new study involving over 120 women, nearly two-thirds of whom had a family history of breast cancer, ultrafast MRI findings revealed a 5 percent increase in malignancy risk for each second increase in the difference between lesion and background parenchymal enhancement (BPE) time to enhancement (TTE).